# Technology Partners

> Technology Partners is a VC fund backing Health Care and Biotechnology. See 55 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Palo Alto, United States
- Total investments: 55
- Last investment: Jan 2016
- Lead investor: 13%
- Last updated: Aug 2026
- Website: http://www.technologypartners.com

Technology Partners is a venture capital firm specialized in seed-, early-, and later-stage venture and private equity investments.

## Contacts

5 contacts available for Technology Partners. Shizune tracks 4 team members at Technology Partners. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/technology-partners?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series B | $5M–$30M |
| Series C | $11M–$54M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 10 | 18% |
| Biotechnology | 8 | 15% |
| Medical | 5 | 9% |
| Energy | 4 | 7% |
| Software | 4 | 7% |

58 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 12 | 22% |
| Series C | 11 | 20% |
| Funding Round | 7 | 13% |
| Series A | 5 | 9% |
| Series D | 4 | 7% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 27 | 49% |
| Pakistan | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Ira Ehrenpreis | General Partner | 14 | https://shizune.co/investors/profile/ira-ehrenpreis |
| Marc van den Berg | General Partner | 23 | https://shizune.co/investors/profile/marc-van-den-berg |
| Sheila Mutter | General Partner and CFO | 0 | https://shizune.co/investors/profile/sheila-mutter |
| Ted Ardell | General Partner | 0 | https://shizune.co/investors/profile/ted-ardell |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Benvenue Medical | Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners. | $23M | Series F | Jan 07, 2016 |  |
| Elcelyx Therapeutics | Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMetfor Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market.Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.Elcelyx is headquartered in San Diego, California. | $40M | Series E | Oct 01, 2015 |  |
| Beamreach | Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation. | $70M | Series D | Aug 16, 2015 |  |
| Kaiam | Kaiam is a private company commercializing photonic integrated circuits. In plain language, they specialize in the design and manufacture of gadgets that help transmit and receive data at very high speeds. The company also manufactures optronics equipment for computer networking and hyper-scale data centers. It also uses micromachined silicon, ademonstrated the CWDM4, a 100 Gigabit-per-second coarse wavelength division multiplexing (CWDM) silicon photonics transceiver using silicon modules and receivers. | $35M |  | Sep 22, 2014 |  |
| Beamreach | Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation. | $31M | Series D | Jul 21, 2014 |  |
| Benvenue Medical | Benvenue Medical, Inc. is developing innovative, minimally invasive surgical solutions to treat spinal disorders. The company is privately held and funded by CRG Partners. | $40M | Series E | Jun 18, 2014 |  |
| Transcend Medical | Transcend Medical is focused on the development of medical devices for the treatment of glaucoma, a cause of adult irreversible blindness. It is estimated that nearly four million people in the US and over 60 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the US, and to over 70million worldwide by the year 2015.In 2005, Transcend Medical was the first company to spin out of ForSight Labs, an incubator solely focused on ophthalmic innovations. Transcend Medical was granted CE mark for the CyPass Micro-Stent® in 2008, and is being evaluated in several clinical studies in the US and abroad, including the COMPASS multi-center clinical trial. | $29M | Series C | Apr 02, 2014 |  |
| Elcelyx Therapeutics | Elcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx’s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMetfor Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market.Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.Elcelyx is headquartered in San Diego, California. | $24.7M | Series C | Feb 20, 2014 |  |
| Kaiam | Kaiam is a private company commercializing photonic integrated circuits. In plain language, they specialize in the design and manufacture of gadgets that help transmit and receive data at very high speeds. The company also manufactures optronics equipment for computer networking and hyper-scale data centers. It also uses micromachined silicon, ademonstrated the CWDM4, a 100 Gigabit-per-second coarse wavelength division multiplexing (CWDM) silicon photonics transceiver using silicon modules and receivers. | $20M |  | Aug 27, 2013 |  |
| Beamreach | Beamreach Solar is developing high-efficiency, low-cost, crystalline silicon solar cells and modules for photovoltaic (PV) electricity generation. | $54.7M | Series C | Aug 22, 2013 |  |

10 of 55 investments shown.

## Co-investors
- [Braemar Energy Ventures](https://shizune.co/investors/profile/braemar-energy-ventures) — VC Fund, 6 deals together
- [Kleiner Perkins](https://shizune.co/investors/profile/kleiner-perkins-caufield-byers) — VC Fund, 6 deals together
- [Domain Associates](https://shizune.co/investors/profile/domain-associates) — VC Fund, 5 deals together
- [Morgenthaler Ventures](https://shizune.co/investors/profile/morgenthaler-ventures) — VC Fund, 5 deals together
- [Advent International](https://shizune.co/investors/profile/advent-international) — VC Fund, 4 deals together
- [DAG Ventures](https://shizune.co/investors/profile/dag-ventures) — VC Fund, 4 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Breakthrough Energy Ventures](https://shizune.co/investors/profile/breakthrough-energy-ventures) — VC Fund
- [Shell Ventures](https://shizune.co/investors/profile/shell-technology-ventures) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Zayn Venture Capital (Formally Zayn Capital)](https://shizune.co/investors/profile/bitrate-venture-capital) — VC Fund
- [Indus Valley Capital](https://shizune.co/investors/profile/indus-valley-capital) — VC Fund
- [Orbit Ventures](https://shizune.co/investors/profile/orbit-ventures) — VC Fund

## Featured in investor lists
- [Clean Energy VC Funds in United States](https://shizune.co/investors/clean-energy-vc-funds-united-states)
- [Clean Energy Investors in United States](https://shizune.co/investors/clean-energy-investors-united-states)
- [Climate Investors in Pakistan](https://shizune.co/investors/climate-investors-pakistan)
- [Climate VC Funds in Pakistan](https://shizune.co/investors/climate-vc-funds-pakistan)
- [SaaS Investors in Pakistan](https://shizune.co/investors/saas-investors-pakistan)
- [Hardware Investors in Pakistan](https://shizune.co/investors/hardware-investors-pakistan)

## FAQ

### What does Technology Partners invest in?

Technology Partners invests primarily in Health Care, Biotechnology and Medical startups, most often at Series B and Series C stage. Most of the 55 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Technology Partners's check size?

Technology Partners typically joins rounds of $5M–$30M at Series B and $11M–$54M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Technology Partners participates in.

### How do I contact Technology Partners?

Public channels for Technology Partners include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Technology Partners?

The team at Technology Partners includes Ira Ehrenpreis (General Partner), Marc van den Berg (General Partner) and Sheila Mutter (General Partner and CFO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co